v3.26.1
GENERAL (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 22, 2025
Jun. 27, 2025
Jun. 26, 2025
Jan. 16, 2025
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Feb. 28, 2025
Dec. 31, 2025
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Gross proceeds                 $ 1,734,720 $ 354,111
Net loss                 20,848,916 15,022,027
Accumulated deficit         $ 81,288,099       81,288,099 60,439,183
Net cash used in operating activities                 14,823,256 12,323,188
Proceeds from issuance of equity       $ 2,000,000.0         $ 6,396,888 $ 5,510,591
Restatement of shares due to reverse stock split   one-for-twenty-eight 1-for-28 reverse stock split              
Common stock outstanding   604,963 16,946,528   2,167,324       2,167,324 428,799
At The Market Offering Agreement [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Proceeds from issuance of equity                 $ 2,250,000  
Proceeds from issuance of common stock           $ 2,340,000        
Convertible Notes Payable [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Gross proceeds from issuance of convertible notes             $ 5,700,000      
Other offering-related expenses             $ 800,000      
Securities Purchase Agreement [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Purchase price per share $ 6.00                  
Gross proceeds $ 6,000,000.0       $ 6,000,000.0          
Securities Purchase Agreement [Member] | Series AA Preferred Stock [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Number of shares issued 300,000                  
Securities Purchase Agreement [Member] | Series AAA Preferred Stock [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Number of shares issued 700,000                  
Standby Equity Purchase Agreement [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Proceeds from issuance of equity                 1,740,000  
Offering expenses                 $ 100,000  
Standby Equity Purchase Agreement [Member] | Maximum [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Purchase ordinary shares               $ 20,000,000.0